Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta
Clinical trial NCT07108153 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07108153
- Sponsor
- Sionna Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2026-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.